Nutra Pharma Corp Stock Price on May 3, 2024
| NPHC Stock | USD 0.0001 0.00 0.00% |
If you're considering investing in Nutra Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Nutra Pharma stands at 0.0001, as last reported on the 12th of December 2024, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. Nutra Pharma is out of control given 3 months investment horizon. Nutra Pharma Corp has Sharpe Ratio of 0.38, which conveys that the firm had a 0.38% return per unit of risk over the last 3 months. We have analyze and collected data for eighteen different technical indicators, which can help you to evaluate if expected returns of 150.0% are justified by taking the suggested risk. Use Nutra Pharma Corp Standard Deviation of 15.11, risk adjusted performance of 0.0819, and Mean Deviation of 4.45 to evaluate company specific risk that cannot be diversified away.
Nutra Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Nutra |
Sharpe Ratio = 0.3817
| Best Portfolio | Best Equity | NPHC | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 392.95 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.38 actual daily | 30 70% of assets perform better |
Based on monthly moving average Nutra Pharma is performing at about 30% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nutra Pharma by adding it to a well-diversified portfolio.
Nutra Pharma Valuation on May 3, 2024
It is possible to determine the worth of Nutra Pharma on a given historical date. On May 3, 2024 Nutra was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Nutra Pharma pink sheet. Still, in general, we apply an absolute valuation method to find Nutra Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nutra Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Nutra Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 2,519,500 | |
05/01/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 14,000 |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 100,001 |
| Backtest Nutra Pharma | | | Nutra Pharma History | | | Nutra Pharma Valuation | Previous | Next |
Nutra Pharma Trading Date Momentum on May 3, 2024
| On May 06 2024 Nutra Pharma Corp was traded for 0.0001 at the closing time. The top price for the day was 0.0001 and the lowest listed price was 0.0001 . The trading volume for the day was 100 K. The trading history from May 6, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
Nutra Pharma Corp Fundamentals Correlations and Trends
By evaluating Nutra Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Nutra Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Nutra financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Nutra Pharma Pink Sheet history
Nutra Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Nutra is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Nutra Pharma Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Nutra Pharma stock prices may prove useful in developing a viable investing in Nutra Pharma
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company was incorporated in 2000 and is based in Plantation, Florida. NUTRA PHARMA operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
Nutra Pharma Pink Sheet Technical Analysis
Nutra Pharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Nutra Pharma Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Nutra Pharma Corp cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Nutra Pharma December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Nutra Pharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nutra Pharma shares will generate the highest return on investment. By undertsting and applying Nutra Pharma pink sheet market strength indicators, traders can identify Nutra Pharma Corp entry and exit signals to maximize returns
Nutra Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Nutra Pharma's price direction in advance. Along with the technical and fundamental analysis of Nutra Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Nutra to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0819 | |||
| Jensen Alpha | 1.37 | |||
| Total Risk Alpha | (0.89) | |||
| Treynor Ratio | 1.27 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Nutra Pink Sheet analysis
When running Nutra Pharma's price analysis, check to measure Nutra Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutra Pharma is operating at the current time. Most of Nutra Pharma's value examination focuses on studying past and present price action to predict the probability of Nutra Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutra Pharma's price. Additionally, you may evaluate how the addition of Nutra Pharma to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |